Literature DB >> 7827291

Spontaneous bacterial peritonitis and culture negative neutrocytic ascites in patients with non-alcoholic liver cirrhosis.

S M al Amri1, A R Allam, I A al Mofleh.   

Abstract

Medical records of 18 patients with spontaneous bacterial peritonitis (SBP) and 19 patients with culture negative neutrocytic ascites (CNNA) were reviewed. The diagnosis of SBP was based on a positive ascitic fluid culture, a polymorphonuclear cell count (PMN) greater than 250 cells/mm3 and the absence of an intra-abdominal source of infection. The diagnosis of CNNA was based on a PMN count greater than 250 cells/mm3, a negative ascitic fluid culture, the absence of an intra-abdominal source of infection and no antibiotic treatment in the preceding 30 days. All patients in both groups had liver cirrhosis, which was mainly (62.2%) due to HBV infection. A single strain, mostly 'a Gram-negative' bacillus, was recovered from the ascitic fluid culture in the vast majority of patients (83%) with SBP. There were no significant differences between the clinical data of both groups. However, the CNNA group had a significantly better Pugh score (P value = 0.01) with a mean score of 9.42 +/- 2.24, compared to the SBP group (10.94 +/- 2.88). The only significant difference in the laboratory data was that the total bilirubin was higher in the SBP group (P < 0.01). Hospital mortality was significantly higher in the SBP patients compared to those with CNNA, 50 and 16%, respectively (P < 0.03). Recurrent ascitic fluid infection occurred in one of five patients who initially presented. In contrast no recurrence was documented in 12 patients with CNNA. Spontaneous bacterial peritonitis is a serious complication of liver cirrhosis with significantly higher mortality than CNNA. A single organism, usually enteric, is the most common causative agent.

Entities:  

Mesh:

Year:  1994        PMID: 7827291     DOI: 10.1111/j.1440-1746.1994.tb01269.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Potential preventability of spontaneous bacterial peritonitis.

Authors:  Saowanee Ngamruengphong; Kenneth Nugent; Ariwan Rakvit; Sreeram Parupudi
Journal:  Dig Dis Sci       Date:  2011-03-11       Impact factor: 3.199

2.  Bacterial translocation in chronic portal hypertensive and common bile duct-ligated growing rats.

Authors:  G Schimpl; P Pesendorfer; G Steinwender; G Feierl; M Ratschek; M E Höllwarth
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

3.  Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats.

Authors:  G Schimpl; P Pesendorfer; G Steinwender; G Feierl; M Ratschek; M E Höllwarth
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial.

Authors:  Seung Up Kim; Young Eun Chon; Chun Kyon Lee; Jun Yong Park; Do Young Kim; Kwang-Hyub Han; Chae Yoon Chon; Sinyoung Kim; Kyu Sik Jung; Sang Hoon Ahn
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

5.  Outcomes in culture positive and culture negative ascitic fluid infection in patients with viral cirrhosis: cohort study.

Authors:  Lubna Kamani; Khalid Mumtaz; Umair S Ahmed; Ailia W Ali; Wasim Jafri
Journal:  BMC Gastroenterol       Date:  2008-12-18       Impact factor: 3.067

6.  The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients.

Authors:  Yesim Cekin; Ayhan Hilmi Cekin; Adil Duman; Ustun Yilmaz; Bayram Yesil; Basak Oguz Yolcular
Journal:  Int J Med Sci       Date:  2013-08-20       Impact factor: 3.738

7.  Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.

Authors:  Chinmaya Kumar Bal; Vikram Bhatia; Ripu Daman
Journal:  BMC Gastroenterol       Date:  2017-05-16       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.